drugset / Trial / NCT01994330
Severe Aortic Stenosis and Acquired Von Willebrand´s Disease: The Impact of Desmopressin in Valve-Replacement Surgery
Phase 4
Completed
13 enrolled
Pontificia Universidad Catolica de Chile
Ferring Pharmaceuticals · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Acquired Von Willebrand disease (type 2A) has been described in patients with severe aortic stenosis, the association of aortic stenosis and Digestive bleeding due to this phenomena has received the name of Heye´s syndrome. We propose that administering Desmopressin (DDAVP) in patients scheduled to aortic valve replacement surgery will reduce blood loss and transfusion rate. this was a pilot study
Timeline
- Start
- 2009-06
- Primary completion
- 2009-12
- Completion
- 2010-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Desmopressin | Peptide | 0.3 ug/kg | — |